Sandbox Reserved 428: Difference between revisions
From Proteopedia
Jump to navigationJump to search
| Line 31: | Line 31: | ||
<scene name='48/483885/Protein_with_inhibitor/3'> Binding of the SAM inhibitor </scene> does not change the structure of the protein to a great degree, the RMS difference of the Cα atoms is 0.49 angstroms. | <scene name='48/483885/Protein_with_inhibitor/3'> Binding of the SAM inhibitor </scene> does not change the structure of the protein to a great degree, the RMS difference of the Cα atoms is 0.49 angstroms. | ||
The relatively <scene name='48/483885/3p8z_binding/3'>hydrophilic SAM ligand binds into the deep pocket</scene>. Favorable hydrogen bonds are satisfied in this interaction along with hydrophobic interactions between the non-polar residues and the non-polar portions of the inhibitor. The bonds are satisfied with the following amino acids on the protein, Phe-133, Ile-147, Gly-148, Glu-149, Arg-160, Arg-163, Val-164, and Leu-182. These residues help to stabilize the charges present on the ligand; they are not all strictly hydrophilic, however they do have portions that allow for hydrogen bonding. | The relatively <scene name='48/483885/3p8z_binding/3'>hydrophilic SAM ligand binds into the deep pocket</scene>. Favorable hydrogen bonds are satisfied in this interaction along with hydrophobic interactions between the non-polar residues and the non-polar portions of the inhibitor. The bonds are satisfied with the following amino acids on the protein, Phe-133, Ile-147, Gly-148, Glu-149, Arg-160, Arg-163, Val-164, and Leu-182. These residues help to stabilize the charges present on the ligand; they are not all strictly hydrophilic, however they do have portions that allow for hydrogen bonding.<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057852/</ref> | ||
Competitive binding on this active site could prove to be an effective drug target; if the SAM ligand cannot bind then the viral RNA cap will not be methylated. This could lead to a less viable virus due to a incorrectly formed 5' cap on the viral RNA. | Competitive binding on this active site could prove to be an effective drug target; if the SAM ligand cannot bind then the viral RNA cap will not be methylated. This could lead to a less viable virus due to a incorrectly formed 5' cap on the viral RNA. | ||